SEQUOIA: Zanubrutinib vs bendamustine

 PDF   12/2021

SEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib versus Bendamustine + Rituximab
(BR) in Patients with Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic
Lymphoma (CLL/SLL)​

Rating

Rate this resource